Liyan Mei
- Molecular Biology
- Immunology
- Pharmacology top 10%
- Cancer Research
- Complementary and alternative medicine top 10%
- Topics
- Advanced Glycation End Products research (5 papers)Immune Response and Inflammation (4 papers)Cancer-related molecular mechanisms research (4 papers)
- Partner nations
- ChinaNetherlandsUkraine
In The Last Decade
Liyan Mei
19 papers receiving 324 citations
Peers
Comparison fields: 5 of 79
- Molecular Biology 144
- Immunology 78
- Pharmacology 65
- Cancer Research 49
- Complementary and alternative medicine 41
Countries citing papers authored by Liyan Mei
This map shows the geographic impact of Liyan Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyan Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyan Mei more than expected).
Fields of papers citing papers by Liyan Mei
This network shows the impact of papers produced by Liyan Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyan Mei. The network helps show where Liyan Mei may publish in the future.
Co-authorship network of co-authors of Liyan Mei
This figure shows the co-authorship network connecting the top 25 collaborators of Liyan Mei. A scholar is included among the top collaborators of Liyan Mei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liyan Mei. Liyan Mei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 12 | |
| 6 | 3 | |
| 7 | 3 | |
| 8 | 7 | |
| 9 | 4 | |
| 10 | 30 | |
| 11 | 14 | |
| 12 | 16 | |
| 13 | 28 | |
| 14 | 24 | |
| 15 | 0 | |
| 16 | 47 | |
| 17 | 31 | |
| 18 | 11 | |
| 19 | 10 | |
| 20 | 11 |
About Liyan Mei
Liyan Mei is a scholar working on Clinical Biochemistry, Pharmacology and Cancer Research, having authored 23 papers that have together received 325 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (5 papers), Immune Response and Inflammation (4 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Pharmacology (65 citations), Complementary and alternative medicine (41 citations) and Clinical Biochemistry (26 citations). Liyan Mei has collaborated with scholars based in China, Netherlands and Ukraine. Frequent co-authors include Maojie Wang, Runyue Huang, Jifei Miao, Quan Wen, Qin Xu, Dongfeng Chen, Hui Li, Yunhui Feng, Qingchun Huang and Sen Ye. Their work appears in journals such as The Journal of Immunology, Scientific Reports and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.